Shock Wave Therapy for Lower Limb Lymphedema

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorParc de Salut Mar

About this trial

This is a double-blind randomized clinical trial to compare the effect of shock wave therapy on lower limb lymphedema. There are two arms: A) complex decongestive therapy + extracorporeal shock waves therapy; B) complex decongestive therapy plus placebo extracorporeal shock waves.

Eligibility criteria

Qualifiers

Patients with lower limb lymphedema

Lymphedema of at least 6 months of evolution

The lymphedema must affect at least the knee to the foot

Moderate or severe lymphedema (grades 2 or 3)

Disqualifiers

Under 18 years of age

Coagulation disorders (hemophilia, treatment with acenocoumarol, etc.)

Current or previous deep vein thrombosis of the lower extremity

Pregnancy

Trial design

Treatments tested in this trial

  • Extracorporeal shock wave therapy by radial device
  • Placebo extracorporeal shock wave therapy by radial device
  • DLT

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators